Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

(2022) Rana Abdelnabi et al.   ANTIVIRAL RESEARCH

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

(2022) Ana Cecilia Ulloa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Impaired detection of omicron by SARS-CoV-2 rapid antigen tests

(2022) Andreas Osterman et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

(2022) Bo Meng et al.   NATURE

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

(2022) Jennifer Hammond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant

(2022) Roby P. Bhattacharyya et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California

(2022) Joseph A. Lewnard et al.   NATURE MEDICINE

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021

(2021) Alexander Lawandi et al.   CLINICAL INFECTIOUS DISEASES

Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave

(2021) Nicolas Banholzer et al.   PLoS One

SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California

(2021) Katherine Lamba et al.   Open Forum Infectious Diseases

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

(2021) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 Vaccine Effectiveness in New York State

(2021) Eli S. Rosenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

(2020) Yeming Wang et al.   LANCET

Re-infection by COVID-19: a real threat for the future management of pandemia?

(2020) Marco Bongiovanni et al.   Infectious Diseases

A living WHO guideline on drugs for covid-19

(2020) François Lamontagne et al.   BMJ-British Medical Journal

The changing demographics of COVID-19

(2020) Priya Venkatesan   Lancet Respiratory Medicine

Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 — United States, May–August 2020

(2020) Jeremy A.W. Gold et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

(2020) Dafna Yahav et al.   CLINICAL MICROBIOLOGY AND INFECTION

Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness Research

(2013) William R. Hersh et al.   MEDICAL CARE

Matching Methods for Causal Inference: A Review and a Look Forward

(2010) Elizabeth A. Stuart   STATISTICAL SCIENCE